Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ele Ferrannini

Showing results (31-40 of 408) with videos related to

Pageof 41
Sort By:
Journal of Diabetes and Its Complications|September 9, 2020
Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era?Niki Katsiki, Ele Ferrannini
Metabolism: Clinical and Experimental|July 30, 2014
β-Cell function in type 2 diabetesEle Ferrannini, Andrea Mari
Diabetes Care|August 22, 2015
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 InhibitorsJulio Rosenstock, Ele Ferrannini
Lancet (London, England)|August 14, 2012
Diabetes and hypertension: the bad companionsEle Ferrannini, William C Cushman
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 2, 2015
Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solutionEle Ferrannini, Maria Laura Manca
European Heart Journal|June 12, 2015
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetesEle Ferrannini, Ralph A DeFronzo
Journal of Clinical Hypertension (Greenwich, Conn.)|February 20, 2018
Nocturnal hypertension in diabetes: Potential target of sodium/glucose cotransporter 2 (SGLT2) inhibitionKazuomi Kario, Michael Weber, Ele Ferrannini
Journal of Hypertension|January 22, 2005
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemiaAnna Solini, Eleonora Santini, Ele Ferrannini
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled studyNadia Caraccio, Ele Ferrannini, Fabio Monzani
BMJ Open Diabetes Research & Care|December 4, 2024
Association between glycosuria and albuminuria in patients with type 2 diabetes from the CREDENCE trial: a mechanistic link?Ele Ferrannini, Anna Solini, Andrea Natali
Pageof 41

Showing results (31-40 of 408) with videos related to

Sort By:
Pageof 41
Journal of Diabetes and Its Complications|September 9, 2020
Anti-inflammatory properties of antidiabetic drugs: A "promised land" in the COVID-19 era?Niki Katsiki, Ele Ferrannini
Metabolism: Clinical and Experimental|July 30, 2014
β-Cell function in type 2 diabetesEle Ferrannini, Andrea Mari
Diabetes Care|August 22, 2015
Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 InhibitorsJulio Rosenstock, Ele Ferrannini
Lancet (London, England)|August 14, 2012
Diabetes and hypertension: the bad companionsEle Ferrannini, William C Cushman
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|January 2, 2015
Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solutionEle Ferrannini, Maria Laura Manca
European Heart Journal|June 12, 2015
Impact of glucose-lowering drugs on cardiovascular disease in type 2 diabetesEle Ferrannini, Ralph A DeFronzo
Journal of Clinical Hypertension (Greenwich, Conn.)|February 20, 2018
Nocturnal hypertension in diabetes: Potential target of sodium/glucose cotransporter 2 (SGLT2) inhibitionKazuomi Kario, Michael Weber, Ele Ferrannini
Journal of Hypertension|January 22, 2005
Enhanced angiotensin II-mediated effects in fibroblasts of patients with familial hypercholesterolemiaAnna Solini, Eleonora Santini, Ele Ferrannini
The Journal of Clinical Endocrinology and Metabolism|April 5, 2002
Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled studyNadia Caraccio, Ele Ferrannini, Fabio Monzani
BMJ Open Diabetes Research & Care|December 4, 2024
Association between glycosuria and albuminuria in patients with type 2 diabetes from the CREDENCE trial: a mechanistic link?Ele Ferrannini, Anna Solini, Andrea Natali
Pageof 41